Laxmi Dental Peer Comparison
NSE: LAXMIDENTL | BSE: 544339
₹195.50
As on 31-Aug-2026IST
Market cap
₹1,075 Cr
Revenue (TTM)
₹287 Cr
P/E Ratio
34.8
P/B Ratio
4.3
Div. Yield
0 %
| Laxmi Dental | Gland Pharma | Medplus Health | Shree Pacetronix | Centenial Surgical | |
|---|---|---|---|---|---|
Market cap (₹ Cr) |
1,075 | 47,647 | 8,072 | 52 | 33 |
Revenue (₹ Cr) |
287 | 6,725 | 7,229 | 21 | 56 |
Net Profit (₹ Cr) |
28.67 | 1,128.79 | 210.43 | 3.24 | -1.45 |
Net Margin (%) |
9.68 | 16.02 | 2.88 | 15.18 | -2.56 |
RoE (%) |
9.14 | 11.51 | 11.02 | 19.12 | -4.88 |
Price to Earnings |
34.80 | 42.21 | 38.35 | 16.08 | -- |
Price-To-Book |
4.25 | 4.48 | 4.04 | 2.80 | 1.19 |
Income Statement (₹ Cr)
| Laxmi Dental | Gland Pharma | Medplus Health | Shree Pacetronix | Centenial Surgical | |
|---|---|---|---|---|---|
|
Operating Revenue
|
286.96 | 6,725.30 | 7,229.43 | 21.19 | 56.25 |
|
Total Income
|
296.08 | 7,045.33 | 7,305.56 | 21.32 | 56.42 |
|
Total Expenditure
|
241.10 | 4,974.15 | 6,619.55 | 15.93 | 50.21 |
|
EBITDA
|
45.85 | 1,751.15 | 609.88 | 5.26 | 6.04 |
|
Depreciation
|
16.62 | 433.87 | 295.17 | 0.74 | 3.97 |
|
EBIT
|
29.23 | 1,317.28 | 314.71 | 4.53 | 2.07 |
|
Interest
|
1.20 | 26.14 | 126.40 | 0.32 | 3.31 |
|
Other Income
|
9.12 | 320.03 | 76.13 | 0.13 | 0.18 |
|
Exceptional Items
|
-5.78 | -24.35 | 0.00 | 0.00 | 0.00 |
|
Profit before Tax
|
31.37 | 1,586.82 | 264.44 | 4.34 | -1.06 |
|
Provision for Tax
|
2.70 | 458.02 | 54.01 | 1.10 | 0.38 |
|
Profit after Tax
|
28.67 | 1,128.79 | 210.43 | 3.24 | -1.45 |
Liabilities (₹ Cr)
| Laxmi Dental | Gland Pharma | Medplus Health | Shree Pacetronix | Centenial Surgical | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
243.32 | 10,357.95 | 1,975.36 | 18.11 | 28.55 |
|
Minority Interest
|
-0.01 | 0.00 | 0.04 | 0.00 | 0.00 |
|
Non-Current Liabilities
|
19.07 | 544.50 | 1,268.58 | 0.36 | 19.67 |
|
Current Liabilities
|
30.79 | 1,608.40 | 689.29 | 7.24 | 31.57 |
|
Total Liabilities
|
284.67 | 11,172.85 | 3,456.02 | 23.05 | 84.58 |
Assets (₹ Cr)
| Laxmi Dental | Gland Pharma | Medplus Health | Shree Pacetronix | Centenial Surgical | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
75.09 | 4,858.96 | 520.92 | 5.33 | 17.19 |
|
Current Assets
|
188.72 | 7,526.79 | 2,068.65 | 19.63 | 60.03 |
|
Total Assets
|
284.67 | 11,172.85 | 3,456.02 | 23.05 | 84.58 |
|
Total Debt*
|
11.37 | 269.21 | 0.00 | 5.07 | 12.26 |
|
Net Current Assets
|
157.93 | 5,918.38 | 1,379.36 | 12.40 | 28.46 |
|
Contingent Liabilities
|
-- | 21.38 | 13.78 | 0.42 | 0.10 |
Cashflow (₹ Cr)
| Laxmi Dental | Gland Pharma | Medplus Health | Shree Pacetronix | Centenial Surgical | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
43.83 | 914.73 | 540.43 | -0.01 | 17.07 |
|
Cash Flow from Investing Activities
|
-29.24 | 1,704.74 | -317.61 | -0.04 | -11.61 |
|
Cash from Financing Activities
|
110.64 | -433.48 | -227.98 | 0.19 | -5.93 |
|
Net Cash Inflow / Outflow
|
125.23 | 2,185.99 | -5.16 | 0.14 | -0.47 |
Ratios
Profitability Ratios
| Laxmi Dental | Gland Pharma | Medplus Health | Shree Pacetronix | Centenial Surgical | |
|---|---|---|---|---|---|
|
ROCE (%)
|
24.97 | 11.97 | 18.22 | 9.13 | 5.09 |
|
ROE (%)
|
9.14 | 11.51 | 11.02 | 19.12 | -4.88 |
|
ROA (%)
|
9.91 | 9.51 | 5.77 | 13.28 | -1.76 |
|
EBIT Margin (%)
|
10.19 | 19.59 | 4.35 | 21.37 | 3.69 |
|
Net Margin (%)
|
9.68 | 16.02 | 2.88 | 15.18 | -2.56 |
|
Cash Profit Margin (%)
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Growth Ratios
| Laxmi Dental | Gland Pharma | Medplus Health | Shree Pacetronix | Centenial Surgical | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
17.10 | 17.57 | 16.79 | 22.55 | 6.70 |
|
EBIT Growth (%)
|
19.09 | 33.69 | 17.15 | 136.57 | 52.84 |
|
Net Profit Growth (%)
|
57.33 | 46.55 | 18.07 | 210.06 | 25.63 |
|
EPS Growth (%)
|
-25.86 | 48.78 | 17.73 | 202.77 | 25.63 |
|
Book Value Growth (%)
|
569.07 | 4.91 | 10.77 | 5.75 | -4.81 |
Valuation Ratios
| Laxmi Dental | Gland Pharma | Medplus Health | Shree Pacetronix | Centenial Surgical | |
|---|---|---|---|---|---|
|
Price / Earnings
|
49.73 | 41.52 | 38.29 | 15.80 | -22.65 |
|
Price / Book Value
|
4.25 | 4.48 | 4.04 | 2.80 | 1.19 |
|
Dividend Yield (%)
|
0.00 | 0.69 | 0.00 | 0.00 | 0.00 |
|
EV/EBITDA
|
21.31 | 25.43 | 12.48 | 10.64 | 7.41 |
|
Market Cap (₹ Cr)
|
2,440.49 | 26,233.01 | 9,091.18 | 22.43 | 40.13 |
Solvency Ratios
| Laxmi Dental | Gland Pharma | Medplus Health | Shree Pacetronix | Centenial Surgical | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.00 | 0.01 | 0.00 | 0.02 | 0.00 |
|
Short term debt to equity ratio
|
-- | -- | -- | 0.33 | 0.40 |
|
Current Ratio
|
6.13 | 4.68 | 3.00 | 2.71 | 1.90 |
|
Quick Ratio
|
5.42 | 3.60 | 1.00 | 2.05 | 0.61 |
|
Interest Coverage
|
27.08 | 61.70 | 3.09 | 14.68 | 0.68 |
Operating Efficiency Ratios
| Laxmi Dental | Gland Pharma | Medplus Health | Shree Pacetronix | Centenial Surgical | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
15.87 | 28.12 | 0.37 | 50.20 | 32.50 |
|
Asset Turnover
|
0.99 | 0.57 | 1.98 | 0.87 | 0.68 |
|
Receivable days
|
47.00 | 99.92 | 0.90 | 122.59 | 126.86 |
|
Inventory Days
|
33.10 | 108.54 | 78.76 | 138.71 | 293.26 |
|
Payable days
|
152.61 | 138.65 | 21.71 | 36.89 | 178.88 |
|
Cash Conversion Cycle
|
-72.51 | 69.81 | 57.95 | 224.42 | 241.25 |